JID: TJPAD ARTICLE IN PRESS [m5GeSdc;February 25, 2025;12:23] The Journal of Prevention of Alzheimer’s Disease xxx (xxxx) xxx Contents lists available at ScienceDirect The Journal of Prevention of Alzheimer’s Disease journal homepage:...
More
JID: TJPAD ARTICLE IN PRESS [m5GeSdc;February 25, 2025;12:23] The Journal of Prevention of Alzheimer’s Disease xxx (xxxx) xxx Contents lists available at ScienceDirect The Journal of Prevention of Alzheimer’s Disease journal homepage: www.elsevier.com/locate/tjpad Review Lecanemab for early Alzheimer’s disease: Appropriate use recommendations from the French federation of memory clinics Nicolas Villain a,b,∗, Vincent Planche c,d, Matthieu Lilamand e,f, Charlotte Cordonnier g, Maria Soto-Martin h,i, Hélène Mollion j, Stéphanie Bombois b, Julien Delrieu h,i , for the French Federation of Memory Clinics Work Group on Anti-Amyloid Immunotherapies a Sorbonne Université, INSERM U1127, CNRS 7225, Institut du Cerveau - ICM, Paris, France b AP-HP Sorbonne Université, Hôpital Pitié-Salpêtrière, Department of Neurology, Institute of Memory and Alzheimer’s Disease, Paris, France c Univ. Bordeaux, CNRS, UMR 5293, Institut des Maladies Neurodégénératives, F-33000 Bordeaux, France d Centre Mémoire Re
Less
